AU2001269422A1 - A method for treating celiac disease - Google Patents

A method for treating celiac disease

Info

Publication number
AU2001269422A1
AU2001269422A1 AU2001269422A AU6942201A AU2001269422A1 AU 2001269422 A1 AU2001269422 A1 AU 2001269422A1 AU 2001269422 A AU2001269422 A AU 2001269422A AU 6942201 A AU6942201 A AU 6942201A AU 2001269422 A1 AU2001269422 A1 AU 2001269422A1
Authority
AU
Australia
Prior art keywords
celiac disease
treating celiac
treating
disease
celiac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269422A
Inventor
Claudio Cavazza
Luigi Mosconi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of AU2001269422A1 publication Critical patent/AU2001269422A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001269422A 2000-07-26 2001-06-15 A method for treating celiac disease Abandoned AU2001269422A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09626151 2000-07-26
US09/626,151 US6348495B1 (en) 1996-06-06 2000-07-26 Method for treating celiac disease
PCT/IT2001/000314 WO2002007715A2 (en) 2000-07-26 2001-06-15 A method for treating celiac disease

Publications (1)

Publication Number Publication Date
AU2001269422A1 true AU2001269422A1 (en) 2002-02-05

Family

ID=24509157

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269422A Abandoned AU2001269422A1 (en) 2000-07-26 2001-06-15 A method for treating celiac disease

Country Status (7)

Country Link
US (1) US6348495B1 (en)
EP (1) EP1305012A2 (en)
KR (1) KR20030036640A (en)
AU (1) AU2001269422A1 (en)
CA (1) CA2417108A1 (en)
MX (1) MXPA03000778A (en)
WO (1) WO2002007715A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (en) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF TOXIC EFFECTS INDUCED BY THE USE OF IMMUNOSOPPRESSING AGENTS.
US20030180358A1 (en) * 2002-03-25 2003-09-25 Stumberger Walter William System and method for affecting the pH state of the contents of the distal bowel in mammals
AUPS252302A0 (en) * 2002-05-23 2002-06-13 Glutagen Pty Ltd Palliative treatment for gluten intolerance
US20050191403A1 (en) * 2002-05-23 2005-09-01 Glutagen Pty Ltd Palliative treatment for gluten intolerance
BRPI0507253A (en) * 2004-01-28 2007-06-26 Nestec Sa nutritional composition to improve skin conditions and prevent skin diseases
US20070071779A1 (en) * 2005-09-26 2007-03-29 Leggit Ingenuity, Llc Compositions for delivering lipophilic agents to the intestinal mucosa and method of making thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701662L (en) * 1987-04-22 1988-10-23 Gelder Nico M Van SETTING AND AGENTS FOR TREATING NEUROLOGICAL DISEASES, EXAMPLE, MIGRAEN THROUGH THE OPERATION OF NERV CELLS
CA1335792C (en) 1987-08-18 1995-06-06 Chaim O. Jacob Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
FR2633163B1 (en) 1988-06-23 1990-10-12 Salomon Sa LACE TIGHTENING DEVICE, PARTICULARLY FOR SHOES
IT1283899B1 (en) 1996-01-26 1998-05-07 Ist Superiore Sanita PEPTIDES AND THEIR USES IN THE CELIAC DISEASE THERAPY
IT1283951B1 (en) * 1996-03-15 1998-05-07 Mendes Srl USE OF ACETYL L-CARNITINE OR ITS PHARMACOLOGICALLY ACCEPTABLE SALTS FOR THERAPEUTIC TREATMENT OR PROPHYLAXIS OF
IT1284661B1 (en) * 1996-06-06 1998-05-21 Sigma Tau Ind Farmaceuti USE OF ALCANOIL L-CARNITINE IN THE THERAPEUTIC TREATMENT OF CHRONIC INTESTINAL INFLAMMATORY DISEASES.
EP1075267A2 (en) 1998-05-06 2001-02-14 Kobenhavns Universitet Treatment of celiac disease
IT1299195B1 (en) * 1998-06-25 2000-02-29 Sigma Tau Healthscience Spa COMPOSITION WITH NEUROPROTECTIVE ACTIVITY FOR THE PREVENTION AND TREATMENT OF STATE-RELATED NERVOUS AND BEHAVIORAL ALTERATIONS

Also Published As

Publication number Publication date
WO2002007715A2 (en) 2002-01-31
EP1305012A2 (en) 2003-05-02
US6348495B1 (en) 2002-02-19
WO2002007715A3 (en) 2002-04-11
KR20030036640A (en) 2003-05-09
CA2417108A1 (en) 2002-01-31
MXPA03000778A (en) 2003-10-15

Similar Documents

Publication Publication Date Title
AU2001238369A1 (en) Method for treating thyroid disorders
AU2001231104A1 (en) Methods for treating diabetes
AU2001245283A1 (en) Methods for treating aneurysms
AU2002215125A1 (en) Well treatment method
HK1053129A1 (en) A method for treating allergies
AU2002220625A1 (en) Method for producing a strip-shaped object
AU2001272920A1 (en) A method for treating herpes viruses
AU2001291882A1 (en) Method for producing polyisobutylphenols
AU2001239243A1 (en) Method for producing nanosuspensions
AU2001229461A1 (en) Method for inhibiting a tumor
AU2001276005A1 (en) Method for treating a neoplasm
AU2001277938A1 (en) Method for treating angina
AU2001285803A1 (en) Method for designing a tyre
AU2001291313A1 (en) Process for making 3-amino-2-chloro-4-methylpyridine
AU2002214487A1 (en) Method for inducing apoptiosis
AU2001269422A1 (en) A method for treating celiac disease
AU2001248372A1 (en) Method for executing access control
AU7664801A (en) A method for hair color treatment
AU2001258827A1 (en) Method for examining WT1-related disease
AU2001243297A1 (en) Method for treating or preventing depression
AU2001283792A1 (en) Method for automatically identifying a directed structure
AU2002220757A1 (en) Method for obtaining azaerythromycin
AU2002212224A1 (en) Method for producing delta1-pyrrolines
AU4696701A (en) Method for carrying out a lottery
AUPQ680300A0 (en) A method